UA32556C2 - (1r,4ar,8ar)-1,2,3,4,5,6,7,8-пергідроізохінолін-1- карбоніл-(l)-пролініл- (l)-аргінін альдегід для використання як антитромбового препарату і фармацевтична композиція на його основі - Google Patents

(1r,4ar,8ar)-1,2,3,4,5,6,7,8-пергідроізохінолін-1- карбоніл-(l)-пролініл- (l)-аргінін альдегід для використання як антитромбового препарату і фармацевтична композиція на його основі

Info

Publication number
UA32556C2
UA32556C2 UA94095984A UA94095984A UA32556C2 UA 32556 C2 UA32556 C2 UA 32556C2 UA 94095984 A UA94095984 A UA 94095984A UA 94095984 A UA94095984 A UA 94095984A UA 32556 C2 UA32556 C2 UA 32556C2
Authority
UA
Ukraine
Prior art keywords
perhydroisoquinolin
prolinyl
carbonyl
pharmaceutical composition
thromboembolic disorder
Prior art date
Application number
UA94095984A
Other languages
English (en)
Russian (ru)
Inventor
Пол Девід Гезеллхен
Пол Девид Гезеллхен
Роберт Теодор Шуман
Original Assignee
Елі Ліллі Енд Компані
Эли Лилли енд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Елі Ліллі Енд Компані, Эли Лилли енд Компани filed Critical Елі Ліллі Енд Компані
Publication of UA32556C2 publication Critical patent/UA32556C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Винахід стосується інгібіторів тромбіну, які є антикоагулянтами для людини і тварин. Він також стосується похідних дипептиду L-пролін-L-аргінін-альдегіду, що має високу протитромбну активність.
UA94095984A 1993-09-14 1994-09-12 (1r,4ar,8ar)-1,2,3,4,5,6,7,8-пергідроізохінолін-1- карбоніл-(l)-пролініл- (l)-аргінін альдегід для використання як антитромбового препарату і фармацевтична композиція на його основі UA32556C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/121,134 US5430023A (en) 1990-09-28 1993-09-14 Tripeptide antithrombotic agents

Publications (1)

Publication Number Publication Date
UA32556C2 true UA32556C2 (uk) 2001-02-15

Family

ID=22394776

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94095984A UA32556C2 (uk) 1993-09-14 1994-09-12 (1r,4ar,8ar)-1,2,3,4,5,6,7,8-пергідроізохінолін-1- карбоніл-(l)-пролініл- (l)-аргінін альдегід для використання як антитромбового препарату і фармацевтична композиція на його основі

Country Status (31)

Country Link
US (1) US5430023A (uk)
EP (1) EP0643073B1 (uk)
JP (1) JPH07149791A (uk)
KR (1) KR100312388B1 (uk)
CN (1) CN1055698C (uk)
AT (1) ATE160574T1 (uk)
AU (1) AU674773B2 (uk)
BR (1) BR9403542A (uk)
CA (1) CA2131982C (uk)
CO (1) CO4290364A1 (uk)
CY (1) CY2072B1 (uk)
CZ (1) CZ286139B6 (uk)
DE (1) DE69407006T2 (uk)
DK (1) DK0643073T3 (uk)
ES (1) ES2110186T3 (uk)
FI (1) FI944231A7 (uk)
GR (1) GR3026115T3 (uk)
HU (1) HU220620B1 (uk)
IL (1) IL110933A (uk)
MY (1) MY112879A (uk)
NO (1) NO310240B1 (uk)
NZ (1) NZ264438A (uk)
PE (1) PE43695A1 (uk)
PH (1) PH31655A (uk)
PL (1) PL176448B1 (uk)
RU (1) RU2105010C1 (uk)
SI (1) SI0643073T1 (uk)
TW (1) TW275622B (uk)
UA (1) UA32556C2 (uk)
YU (1) YU54194A (uk)
ZA (1) ZA947015B (uk)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69314478T2 (de) * 1992-03-04 1999-02-11 Gyogyszerkutato Intezet Kft., Budapest Neuartige antikoagulierende peptidderivate und arzneimittel die solche enthalten so wie entsprechendes herstellungsverfahren
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
AU1884395A (en) * 1994-03-04 1995-09-18 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5691356A (en) * 1994-03-21 1997-11-25 Bristol-Myers Squibb Company Disubstituted heterocyclic thrombin inhibitors
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US6069130A (en) * 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
JP3539607B2 (ja) * 1997-02-19 2004-07-07 シャープ株式会社 空気調和機の運転制御システム
US6214841B1 (en) 1997-05-15 2001-04-10 Eli Lilly And Company Antithrombotic compound
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
WO1999064395A1 (en) * 1998-06-11 1999-12-16 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6172081B1 (en) 1999-06-24 2001-01-09 Novartis Ag Tetrahydroisoquinoline 3-carboxamide derivatives
JP4373792B2 (ja) * 2002-02-11 2009-11-25 ゴールド−ティー テック インコーポレイテッド 血栓形成を予防する方法
US7205315B2 (en) 2003-09-27 2007-04-17 Sanofi-Aventis Deutschland Gmbh Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
RU2377246C2 (ru) * 2007-06-08 2009-12-27 Государственное учреждение гематологический научный центр Российской академии медицинских наук (ГУ ГНЦ РАМН) Синтетическое производное пептида, проявляющее антикоагулянтную активность
CN102391360B (zh) * 2011-11-02 2013-07-03 东南大学 一种抗血栓和血小板聚集的小肽
KR102388531B1 (ko) * 2021-07-07 2022-04-21 이재호 특장차용 스마트 유압 시스템

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
DE3827415A1 (de) * 1988-08-12 1990-02-15 Behringwerke Ag Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents
US5252566A (en) * 1991-11-12 1993-10-12 Eli Lilly And Company Antithrombotic agents
US5250660A (en) * 1991-11-12 1993-10-05 Eli Lilly And Company Peptide purification process

Also Published As

Publication number Publication date
FI944231A0 (fi) 1994-09-13
NO310240B1 (no) 2001-06-11
ZA947015B (en) 1996-03-12
NZ264438A (en) 1996-06-25
IL110933A (en) 1998-12-27
HU9402626D0 (en) 1994-11-28
CN1106819A (zh) 1995-08-16
FI944231L (fi) 1995-03-15
MY112879A (en) 2001-10-31
ATE160574T1 (de) 1997-12-15
NO943402D0 (no) 1994-09-13
AU7294894A (en) 1995-03-30
NO943402L (no) 1995-03-15
PE43695A1 (es) 1995-12-09
CA2131982C (en) 2003-07-29
EP0643073A1 (en) 1995-03-15
IL110933A0 (en) 1994-11-28
CY2072B1 (en) 1998-09-11
CN1055698C (zh) 2000-08-23
CZ286139B6 (cs) 2000-01-12
EP0643073B1 (en) 1997-11-26
DE69407006T2 (de) 1998-04-16
PL305009A1 (en) 1995-03-20
SI0643073T1 (en) 1998-08-31
PL176448B1 (pl) 1999-05-31
PH31655A (en) 1999-01-12
AU674773B2 (en) 1997-01-09
FI944231A7 (fi) 1995-03-15
KR950008534A (ko) 1995-04-19
YU54194A (sh) 1997-01-08
HU220620B1 (hu) 2002-03-28
CZ222094A3 (en) 1995-03-15
ES2110186T3 (es) 1998-02-01
RU94034734A (ru) 1996-07-20
CO4290364A1 (es) 1996-04-17
HUT67849A (en) 1995-05-29
BR9403542A (pt) 1995-06-20
JPH07149791A (ja) 1995-06-13
DE69407006D1 (de) 1998-01-08
GR3026115T3 (en) 1998-05-29
CA2131982A1 (en) 1995-03-15
RU2105010C1 (ru) 1998-02-20
KR100312388B1 (ko) 2001-12-28
TW275622B (uk) 1996-05-11
US5430023A (en) 1995-07-04
DK0643073T3 (da) 1997-12-29

Similar Documents

Publication Publication Date Title
UA32556C2 (uk) (1r,4ar,8ar)-1,2,3,4,5,6,7,8-пергідроізохінолін-1- карбоніл-(l)-пролініл- (l)-аргінін альдегід для використання як антитромбового препарату і фармацевтична композиція на його основі
ATE176241T1 (de) 3-amino-2-oxo-piperidinessigsäurederivate, die eine argininnachahmende verbindung, mit enzyminhibitorischen wirkung enthalten
DE69716823D1 (de) Thrombin-Inhibitoren als anticoagulierende Mittel
BR9713186A (pt) Inibidores de metaloprotease 1,3-diheterocìclicos
ATE231496T1 (de) Saccharinderivate als proteolytische enzyminhibitoren
BR9612191A (pt) Inibidores de enzima conversora de interleuciana-1beta
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
FI942625A0 (fi) Peptidisiä fosfinyylioksimetyyliketoneja interleukiini-1beta-muuttuvan entsyymin inhibiittoreina
BG104780A (en) Inhibitors of phospholipase enzymes
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
BR9712086A (pt) Inibidores1,4-heterocìclicos de metaloproteinases
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
DE69232929D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
BR9811099A (pt) Inibidores de urocinase
BR9713178A (pt) Inbidores espirocìclicos da metaloprotease.
PT888271E (pt) Derivados de benzamidina substituidos com derivados de aminoacidos e hidroxiacidos e sua utilizacao como anticoagulantes
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
FI951298A0 (fi) 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus
NO933524D0 (no) Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav
EA200000240A1 (ru) Соединения, препятствующие эффекту раннего превращения лекарственных средств
NO177312C (no) Fremgangsmåte for fremstilling av hirudinderivater med forsinket virkning
ES2150461T3 (es) Derivados de amidinofenilalanina, proceso para su preparacion, su empleo y agentes que los contienen como anticoagulantes.
ATE255594T1 (de) Hepatitis b inhibitoren
DE69509235D1 (de) Arginin ahnliche derivate als enzym-inhibitoren
EA199800546A1 (ru) Производные тиола, обладающие (ace/nep) ингибирующим действием на металлопептидазу